Lee, S., Song, H., & Kwon, Y. (2026). A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy. Pharmaceuticals (14248247), 19(7), 1047. https://doi.org/10.3390/ph19071047
Chicago Style (17th ed.) CitationLee, Sangmin, Hyeseon Song, and Yeonwoo Kwon. "A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy." Pharmaceuticals (14248247) 19, no. 7 (2026): 1047. https://doi.org/10.3390/ph19071047.
MLA (9th ed.) CitationLee, Sangmin, et al. "A Lineup for Next Anti-Obesity Medicines: Beyond Incretin-Based Pharmacotherapy." Pharmaceuticals (14248247), vol. 19, no. 7, 2026, p. 1047, https://doi.org/10.3390/ph19071047.
Warning: These citations may not always be 100% accurate.